{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:39:47Z","timestamp":1787071187574,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Backgrounds:<\/jats:title>\n                    <jats:p>Most of the cancer patients with solid tumor are subjected to chemotherapy with cisplatin (CP) in clinic. However, the most side effect of CP is nephrotoxicity, which limits the treatment. The aim of study was to develop a general consensus statement for CP therapy in clinic to limit the drug-induced nephrotoxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 30 oncologist-hematologists, adult and pediatric nephrologists, radiation oncologists, clinical pathologist clinical pharmacologist, and renal physiologist participated in a workshop, and in order to reduce the incidence of CP-induced nephrotoxicity, a general consensus was developed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The developed general consensus was focused on some items such as age, sex, female hormone, nonsteroidal anti-inflammatory drugs (NSAID), renin\u2013angiotensin system inhibitor drugs, glomerular filtration rate, hydration methods, contrasts, antioxidants, dextrose, and magnesium.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The agreement between participants for CP therapy in clinic was achieved, and this general consensus was announced to be implemented in the hospitals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijpvm.ijpvm_445_19","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T09:07:10Z","timestamp":1716973630000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["The Prevention of Cisplatin-Induced Nephrotoxicity: A General Consensus Statement of a Group of Oncologist-Hematologists, Adult and Pediatric Nephrologists, Radiation Oncologists, Clinical Pathologists, Clinical Pharmacologists, and Renal Physiologists on Cisplatin Therapy in Cancer Patients"],"prefix":"10.4103","volume":"13","author":[{"given":"Farzaneh","family":"Ashrafi","sequence":"first","affiliation":[{"name":"Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"},{"name":"Department of Internal Medicine, Oncology- Hematology Section, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Mortazavi","sequence":"additional","affiliation":[{"name":"Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"},{"name":"Department of Internal Medicine, Nephrology Section, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Nematbakhsh","sequence":"additional","affiliation":[{"name":"Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"},{"name":"Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran"},{"name":"IsfahanMN Institute of Basic and Applied Sciences Research, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"R1-20250813","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/10408444.2011.602662","article-title":"An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity","volume":"41","author":"Sanchez-Gonzalez","year":"2011","journal-title":"Crit Rev Toxicol"},{"key":"R2-20250813","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/sj.bjc.6600884","article-title":"Weekly high-dose cisplatin is a feasible treatment option: Analysis on prognostic factors for toxicity in 400 patients","volume":"88","author":"de Jongh","year":"2003","journal-title":"B J Cancer"},{"key":"R3-20250813","first-page":"1703","article-title":"Age and gender related renal side effects of cisplatin in animal model","volume":"18","author":"Pezeshki","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"R4-20250813","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1016\/j.fct.2008.07.030","article-title":"Ontogenic aspects of cisplatin-induced nephrotoxicity in rats","volume":"46","author":"Ali","year":"2008","journal-title":"Food Chem Toxicol"},{"key":"R5-20250813","first-page":"295","article-title":"Cisplatin-induced nephrotoxicity; protective supplements and gender differences","volume":"18","author":"Nematbakhsh","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"R6-20250813","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12011-014-9945-3","article-title":"Gender differences influence renal injury in cisplatin-treated rats: Biochemical evaluation","volume":"158","author":"Aydin","year":"2014","journal-title":"Biol Trace Elem Res"},{"key":"R7-20250813","doi-asserted-by":"crossref","first-page":"818","DOI":"10.5812\/numonthly.10128","article-title":"Gender difference in Cisplatin-induced nephrotoxicity in a rat model: Greater intensity of damage in male than female","volume":"5","author":"Nematbakhsh","year":"2013","journal-title":"Nephrourol Mon"},{"key":"R8-20250813","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.nephro.2004.12.001","article-title":"[Anticancer drug-induced nephrotoxicity]","volume":"1","author":"Isnard-Bagnis","year":"2005","journal-title":"Nephrol Ther"},{"key":"R9-20250813","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/0971-6580.111568","article-title":"Evidence against protective role of sex hormone estrogen in Cisplatin-induced nephrotoxicity in ovarectomized rat model","volume":"20","author":"Pezeshki","year":"2013","journal-title":"Toxicol Int"},{"key":"R10-20250813","doi-asserted-by":"crossref","first-page":"136","DOI":"10.18585\/inabj.v11i2.502","article-title":"Dextrose hydration may promote cisplatin-induced nephrotoxicity in rats: Gender-related difference","volume":"11","author":"Karimi","year":"2019","journal-title":"Indones Biomed J"},{"key":"R11-20250813","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/pbc.21695","article-title":"Renal late effects in patients treated for cancer in childhood: A report from the Children's oncology group","volume":"51","author":"Jones","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R12-20250813","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jbt.21567","article-title":"Hesperidin and rutin, antioxidant citrus flavonoids, attenuate cisplatin-induced nephrotoxicity in rats","volume":"28","author":"Kamel","year":"2014","journal-title":"J Biochem Mol Toxicol"},{"key":"R13-20250813","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1034\/j.1600-0773.2000.pto860507.x","article-title":"Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: Antioxidant defense system","volume":"86","author":"Somani","year":"2000","journal-title":"Pharmacol Toxicol"},{"key":"R14-20250813","doi-asserted-by":"crossref","first-page":"612675","DOI":"10.5402\/2013\/612675","article-title":"Sex-related difference in nitric oxide metabolites levels after nephroprotectant supplementation administration against cisplatin-induced nephrotoxicity in wistar rat model: The role of vitamin E, erythropoietin, or N-Acetylcysteine","volume":"2013","author":"Nematbakhsh","year":"2013","journal-title":"ISRN Nephrol"},{"key":"R15-20250813","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5301\/jn.5000018","article-title":"Administration of vitamin E and losartan as prophylaxes in cisplatin-induced nephrotoxicity model in rats","volume":"25","author":"Nematbakhsh","year":"2012","journal-title":"J Nephrol"},{"key":"R16-20250813","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.etp.2008.04.016","article-title":"Preventive effect of aminoguanidine compared to vitamin E and C on cisplatin-induced nephrotoxicity in rats","volume":"61","author":"Atasayar","year":"2009","journal-title":"Exp Toxicol Pathol"},{"key":"R17-20250813","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s11096-018-0677-x","article-title":"Evaluation of the effect of acetazolamide versus mannitol on cisplatin-induced nephrotoxicity, a pilot study","volume":"40","author":"El Hamamsy","year":"2018","journal-title":"Int J Clin Pharm"},{"key":"R18-20250813","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/1078155218771461","article-title":"A case-control study analyzing mannitol dosing for prevention of cisplatin-induced acute nephrotoxicity","volume":"25","author":"Dhillon","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"R19-20250813","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/1078155216688341","article-title":"Should mannitol be reinstated in prevention of cisplatin-induced nephrotoxicity?","volume":"24","author":"Adam","year":"2018","journal-title":"J Oncol Pharm Pract"},{"key":"R20-20250813","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1345\/aph.1Q333","article-title":"The role of mannitol as a nephroprotectant in patients receiving cisplatin therapy","volume":"46","author":"Morgan","year":"2012","journal-title":"Ann Pharmacother"},{"key":"R21-20250813","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/1078155216656927","article-title":"Mannitol for the prevention of cisplatin-induced nephrotoxicity: A retrospective comparison of hydration plus mannitol versus hydration alone in inpatient and outpatient regimens at a large academic medical center","volume":"23","author":"Williams","year":"2017","journal-title":"J Oncol Pharm Pract"},{"key":"R22-20250813","first-page":"F96","article-title":"[Chemotherapy and renal toxicity]","volume":"95 FMC Onco","author":"Launay-Vacher","year":"2008","journal-title":"Bull Cancer"},{"key":"R23-20250813","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/2277-9175.175253","article-title":"Effect of enalapril in cisplatin-induced nephrotoxicity in rats; gender-related difference","volume":"5","author":"Zamani","year":"2016","journal-title":"Adv Biomed Res"},{"key":"R24-20250813","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3109\/0886022X.2012.700886","article-title":"The role of angiotensin II receptor 1 (AT1) blockade in cisplatin-induced nephrotoxicity in rats: Gender-related differences","volume":"34","author":"Haghighi","year":"2012","journal-title":"Ren Fail"},{"key":"R25-20250813","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0971-4065.160337","article-title":"Nephroprotective effect of estrogen and progesterone combination on cisplatin-induced nephrotoxicity in ovariectomized female rats","volume":"26","author":"Ghasemi","year":"2016","journal-title":"Indian J Nephrol"},{"key":"R26-20250813","first-page":"890310","article-title":"Estrogen abolishes protective effect of erythropoietin against cisplatin-induced nephrotoxicity in ovariectomized rats","volume":"2012","author":"Pezeshki","year":"2012","journal-title":"ISRN Oncol"},{"key":"R27-20250813","doi-asserted-by":"crossref","first-page":"284896","DOI":"10.1155\/2012\/284896","article-title":"Vitamin E, vitamin C, or losartan is not nephroprotectant against cisplatin-induced nephrotoxicity in presence of estrogen in ovariectomized rat model","volume":"2012","author":"Nematbakhsh","year":"2012","journal-title":"Int J Nephrol"},{"key":"R28-20250813","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/0971-6580.117256","article-title":"Effects of fennel essential oil on cisplatin-induced nephrotoxicity in ovariectomized rats","volume":"20","author":"Mazaheri","year":"2013","journal-title":"Toxicol Int"},{"key":"R29-20250813","article-title":"Baseline glomerular filtration rate and cisplatin- induced renal toxicity in urothelial cancer patients","author":"Loh","year":"2017","journal-title":"Clin Genitourinary Cancer"},{"key":"R30-20250813","doi-asserted-by":"crossref","first-page":"273","DOI":"10.14735\/amko2015273","article-title":"Estimated glomerular filtration rate in oncology patients before cisplatin chemotherapy","volume":"28","author":"Salek","year":"2015","journal-title":"Klin Onkol"},{"key":"R31-20250813","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0300-483X(90)90166-E","article-title":"Influence of streptozotocin (STZ)-induced diabetes, dextrose diuresis and acetone on cisplatin nephrotoxicity in Fischer 344 (F344) rats","volume":"60","author":"Scott","year":"1990","journal-title":"Toxicology"},{"key":"R32-20250813","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s13318-017-0436-8","article-title":"Pharmacokinetic-pharmacodynamic analysis of cisplatin with hydration and mannitol diuresis: The contribution of urine cisplatin concentration to nephrotoxicity","volume":"43","author":"Fukushima","year":"2018","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"R33-20250813","first-page":"1789","article-title":"Mannitol to prevent cisplatin-induced nephrotoxicity in patients with squamous cell cancer of the head and neck (SCCHN) receiving concurrent therapy","volume":"24","author":"McKibbin","year":"2016","journal-title":"Support Care Cancer"},{"key":"R34-20250813","first-page":"1085","article-title":"Vitamin C protects against cisplatin-induced nephrotoxicity and damage without reducing its effectiveness in C57BL\/6 mice xenografted with Lewis lung carcinoma","volume":"66","author":"Chen","year":"2014","journal-title":"NutrCancer"},{"key":"R35-20250813","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbt.21833","article-title":"Vitamin E mitigates cisplatin-induced nephrotoxicity due to reversal of oxidative\/nitrosative stress, suppression of inflammation and reduction of total renal platinum accumulation","volume":"31","author":"Darwish","year":"2017","journal-title":"J Biochem Mol Toxicol"},{"key":"R36-20250813","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/DCT-100108468","article-title":"Cisplatin induces acute renal failure by impairing antioxidant system in guinea pigs: Effects of antioxidant supplementation on the cisplatin nephrotoxicity","volume":"25","author":"Durak","year":"2002","journal-title":"Drug Chem Toxicol"},{"key":"R37-20250813","first-page":"658","article-title":"Influence of magnesium and parathyroid hormone on cisplatin-induced nephrotoxicity in esophageal squamous cell carcinoma","volume":"15","author":"Konishi","year":"2018","journal-title":"Oncol Lett"},{"key":"R38-20250813","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.lfs.2017.08.028","article-title":"Magnesium co-administration decreases cisplatin-induced nephrotoxicity in the multiple cisplatin administration","volume":"189","author":"Saito","year":"2017","journal-title":"Life Sci"},{"key":"R39-20250813","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejphar.2017.05.034","article-title":"Magnesium attenuates cisplatin-induced nephrotoxicity by regulating the expression of renal transporters","volume":"811","author":"Saito","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"R40-20250813","first-page":"481","article-title":"Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity","volume":"25","author":"Saito","year":"2017","journal-title":"Support Care Cancer"},{"key":"R41-20250813","doi-asserted-by":"crossref","first-page":"e101902","DOI":"10.1371\/journal.pone.0101902","article-title":"Risk factors for cisplatin-induced nephrotoxicity and potential of magnesium supplementation for renal protection","volume":"9","author":"Kidera","year":"2014","journal-title":"PloS One"},{"key":"R42-20250813","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/jjco\/hyu004","article-title":"Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: A retrospective study","volume":"44","author":"Yoshida","year":"2014","journal-title":"Japanese J Clin Oncol"},{"key":"R43-20250813","doi-asserted-by":"crossref","first-page":"884","DOI":"10.5812\/numonthly.11624","article-title":"Effect of oral administration of magnesium on Cisplatin-induced nephrotoxicity in normal and streptozocin-induced diabetic rats","volume":"5","author":"Soltani","year":"2013","journal-title":"Nephrourol Mon"},{"key":"R44-20250813","first-page":"637","article-title":"The role of magnesium supplementation in cisplatin-induced nephrotoxicity in a rat model: No nephroprotectant effect","volume":"3","author":"Ashrafi","year":"2012","journal-title":"Int J Prev Med"},{"key":"R45-20250813","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/mpo.10335","article-title":"Cisplatin nephrotoxicity affects magnesium and calcium metabolism","volume":"41","author":"Goren","year":"2003","journal-title":"Med Pediatr Oncol"}],"container-title":["International Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpvm.IJPVM_445_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:42:48Z","timestamp":1787067768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpvm.IJPVM_445_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijpvm.ijpvm_445_19","relation":{},"ISSN":["2008-7802","2008-8213"],"issn-type":[{"value":"2008-7802","type":"print"},{"value":"2008-8213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"2019-11-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}